Superior Trunk Block Versus Combined Suprascapular and Axillary Nerve Blocks

November 11, 2026 updated by: Tarek Ahmed Sayed, Assiut University

Ultrasound-Guided Superior Trunk Block Versus Combined Suprascapular and Axillary Nerve Blocks on Diaphragmatic Function and Postoperative Analgesia in Patients Undergoing Arthroscopic Shoulder Surgery

This randomized controlled trial aims to compare the effects of ultrasound-guided superior trunk block versus combined suprascapular and axillary nerve blocks on diaphragmatic function and postoperative analgesia in patients undergoing arthroscopic shoulder surgery.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Arthroscopic shoulder surgery is associated with significant postoperative pain. The interscalene brachial plexus block is effective but carries a risk of hemidiaphragmatic paralysis.

The superior trunk block targets the C5-C6 roots after they form the superior trunk and aims to reduce phrenic nerve involvement. Combined blockade of the suprascapular and axillary nerves provides shoulder analgesia with potentially less diaphragmatic impact.

This study will randomize patients undergoing elective unilateral arthroscopic shoulder surgery to receive either ultrasound-guided superior trunk block or combined ultrasound-guided suprascapular and axillary nerve blocks, and will assess diaphragmatic function and postoperative pain.

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • American Society of Anesthesiologists physical status I-II
  • Age 18-65 years
  • Scheduled for elective unilateral arthroscopic shoulder surgery
  • Written informed consent

Exclusion Criteria:

  • Patient refusal
  • Known allergy to local anesthetics
  • Pre-existing phrenic nerve palsy or diaphragmatic dysfunction
  • Severe chronic obstructive pulmonary disease
  • Coagulopathy or bleeding diathesis
  • Infection at the injection site
  • Pre-existing neurological deficit in the operative arm
  • Pregnancy or breastfeeding
  • Body mass index greater than 35 kg/m²
  • Bilateral shoulder surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Superior Trunk Block

Patients will receive ultrasound-guided superior trunk block with 10 mL of 0.25% bupivacaine.

Ultrasound-guided injection of local anesthetic around the superior trunk of the brachial plexus.

Active Comparator: Combined Suprascapular and Axillary Nerve Blocks

Patients will receive combined ultrasound-guided suprascapular and axillary nerve blocks with 5 mL of 0.5% ropivacaine for each nerve (total 10 mL).

Ultrasound-guided injection of local anesthetic around the suprascapular nerve and the axillary nerve.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with hemidiaphragmatic paralysis
Time Frame: At 30 minutes after block

Number of patients who develop hemidiaphragmatic paralysis assessed by ultrasound measurement of diaphragmatic excursion at 30 minutes after the block.

At 30 minutes after block

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diaphragmatic excursion
Time Frame: At 30 minutes after block

Mean diaphragmatic excursion measured by ultrasound in centimeters during quiet breathing and deep inspiration.

At 30 minutes after block
Pain score at rest
Time Frame: At 24 hours

Mean pain score at rest measured by numerical rating scale (range 0 to 10, higher scores indicate more pain).

At 24 hours
Total opioid consumption
Time Frame: At 24 hours

Mean total opioid consumption in morphine milligram equivalents in the first 24 hours after surgery.

At 24 hours
Time to first rescue analgesia
Time Frame: At 24 hours

Mean time from end of surgery to first request for rescue analgesia in hours.

At 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Samy A Amr, prof, Anaesthesia , ICU and pain management Department, Assiut University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 26, 2026

Primary Completion (Estimated)

November 26, 2027

Study Completion (Estimated)

March 10, 2028

Study Registration Dates

First Submitted

November 11, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STB-vs-SSANB-Shoulder-Assiut

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.